Contribution of blood platelets to vascular pathology in Alzheimer’s disease
Cerebral amyloid angiopathy (CAA) is a critical factor in the pathogenesis of Alzheimer’s disease (AD). In the clinical setting, nearly 98% AD patients have CAA, and 75% of these patients are rated as severe CAA. It is characterized by the deposition of the β-amyloid peptide (mainly Aβ40) in the wal...
Main Authors: | Zhang, Wei, Huang, Wei, Jing, Fang |
---|---|
Format: | Online |
Language: | English |
Published: |
Dove Medical Press
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825710/ |
Similar Items
-
Blood Platelets in the Progression of Alzheimer’s Disease
by: Gowert, Nina S., et al.
Published: (2014) -
Platelets in pulmonary vascular physiology and pathology
by: Kroll, Michael H., et al.
Published: (2012) -
Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer’s disease
by: Canobbio, Ilaria, et al.
Published: (2015) -
Blood-Based Proteomic Biomarkers of Alzheimer’s Disease Pathology
by: Baird, Alison L., et al.
Published: (2015) -
The overlap between vascular disease and Alzheimer’s disease - lessons from pathology
by: Attems, Johannes, et al.
Published: (2014)